TABLE 3.
Adverse events.
| GNRI<92 (n = 45) | GNRI>92 (n = 125) | p value | |||
|---|---|---|---|---|---|
| n | % | n | % | ||
| Neutropenia | 0.028* | ||||
| Grade 1/2 | 4 | (8.89%) | 30 | (24.00%) | |
| Grade 3/4 | 15 | (33.33%) | 48 | (38.40%) | |
| Febrile neutropenia | 0.001** | ||||
| Grade 3/4 | 16 | (35.56%) | 15 | (12.00%) | |
| Rash a | 0.683 | ||||
| Grade 1/2 | 1 | (2.22%) | 7 | (5.60%) | |
| Fatigue | 0.086 | ||||
| Grade 1/2 | 11 | (24.44%) | 14 | (11.20%) | |
| Grade 3/4 | 0 | (0.00%) | 1 | (0.80%) | |
| Elevated AST/ALT a | 0.006** | ||||
| Grade 1/2 | 8 | (17.78%) | 5 | (4.00%) | |
| Diarrhea a | 0.286 | ||||
| Grade 1/2 | 2 | (4.44%) | 2 | (1.60%) | |
| Nausea | 0.247 | ||||
| Grade 1/2 | 6 | (13.33%) | 17 | (13.60%) | |
| Grade 3/4 | 1 | (2.22%) | 0 | (0.00%) | |
Chi-Square test.
a
Fisher's Exact test. *p< 0.05, **p< 0.01.
GNRI, Geriatric Nutritional Risk Index; AST, Aspartate aminotransferase; ALT, Alanine aminotransferase.